-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Vertex Pharmaceuticals, Raises Price Target to $414

Benzinga·11/04/2025 14:27:04
Listen to the news
Barclays analyst Gena Wang maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and raises the price target from $408 to $414.